As a significant expansion of DryLab®4 functionalities, we are happy to announce the release of our software’s newest module – DryLab’s Empower Automation.
This new module enables an automated method modelling on three levels of DryLab’s AQbD-workflow: it does so by creating, performing and retrieving input runs, automating the model’s verification and validating DryLab’s in-silico robustness assessment.
Automated Method Development
The new completely automated and digitalised integration between DryLab®4 and Waters Empower equips the chromatographer with an easy-to-use modelling platform. It allows for science-based, flexible decisions in retention modelling, mitigated risk, improved analytical throughput and a holistic approach to state-of-the-art method development.
The Empower module generates method sets and runs them in the most economic and ecological order, taking into account subsequent equilibration steps. DryLab® then accesses Empower’s data-stream for additional peak-information on peak shapes (Tf, w0.5) and peak names that can be directly used to adjust the model.
Compliant with the recently introduced ICH Q12 guideline for assessing the robustness of an analytical method the new DryLab-Empower connection module is one of the main reasons why pharmaceutical companies are opting for automated method development. It promises to further facilitate the R&D process to reduce the time between drug discovery and approval by optimising the use of instrumentation and determining the most robust method conditions. By reducing costs and ensuring full compliance with FDA/EMA requirements for Method Lifecycle Management, it improves the quality of results and ensures patient safety, while simultaneously reducing Quality Control (QC) costs.
For more information and a free demo, please click here: https://drylab-empower.molnar-institute.com.